Back
Contineum Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
CTNM
Contineum Therapeutics, Inc.
Last Price:
$11.40
Seasonality Move:
-24.83%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and CTNM is experiencing slight selling pressure.
Contineum Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.95 | Buy |
| 20-day SMA: | 11.74 | Buy |
| 50-day SMA: | 11.35 | Buy |
| 200-day SMA: | 7.88 | Buy |
| 8-day EMA: | 12.09 | Sell |
| 20-day EMA: | 11.82 | Buy |
| 50-day EMA: | 11.32 | Buy |
| 200-day EMA: | 7.16 | Buy |
Contineum Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 53.56 | Buy |
| Chaikin Money Flow: | -135848 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.86 - 12.32) | Buy |
| Bollinger Bands (100): | (9.44 - 12.4) | Buy |
Contineum Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Contineum Therapeutics, Inc. Stock
Is Contineum Therapeutics, Inc. Stock a Buy?
-
Contineum Therapeutics, Inc. share price is 12.07 while CTNM 8-day simple moving average is 11.95, which is a Buy signal.
-
The stock price of CTNM is 12.07 while Contineum Therapeutics, Inc. 20-day SMA is 11.74, which makes it a Buy.
-
Contineum Therapeutics, Inc. 50-day simple moving average is 11.35 while CTNM share price is 12.07, making it a Buy technically.
-
CTNM stock price is 12.07 and Contineum Therapeutics, Inc. 200-day simple moving average is 7.88, creating a Buy signal.
CTNM Technical Analysis vs Fundamental Analysis
Buy
59
Contineum Therapeutics, Inc. (CTNM)
is a Buy
Is Contineum Therapeutics, Inc. a Buy or a Sell?
-
Contineum Therapeutics, Inc. stock is rated a BuyThe current Contineum Therapeutics, Inc. [CTNM] share price is $12.07. The Score for CTNM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Contineum Therapeutics, Inc. Stock Info
Market Cap:
312.3M
Price in USD:
12.07
Share Volume:
358.1K
Contineum Therapeutics, Inc. 52-Week Range
52-Week High:
15.25
52-Week Low:
3.35
Buy
59
Contineum Therapeutics, Inc. (CTNM)
is a Buy
Contineum Therapeutics, Inc. Share Price Forecast
-
What is the Contineum Therapeutics, Inc. stock price today?The Contineum Therapeutics, Inc. stock price is 12.07 USD today.
-
Will CTNM stock go up or go down?Contineum Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Contineum Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Contineum Therapeutics, Inc. is not overvalued.
Is Contineum Therapeutics, Inc. Stock a Buy?
-
Contineum Therapeutics, Inc. share price is 12.07 while CTNM 8-day exponential moving average is 12.09, which is a Sell signal.
-
The stock price of CTNM is 12.07 while Contineum Therapeutics, Inc. 20-day EMA is 11.82, which makes it a Buy.
-
Contineum Therapeutics, Inc. 50-day exponential moving average is 11.32 while CTNM share price is 12.07, making it a Buy technically.
-
CTNM stock price is 12.07 and Contineum Therapeutics, Inc. 200-day simple moving average is 7.16, creating a Buy signal.
Fundamental Analysis of Contineum Therapeutics, Inc.
Is Contineum Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Contineum Therapeutics, Inc.
Should I short Contineum Therapeutics, Inc. stock?
-
CTNM Moving Average Covergence Divergence (MACD) indicator is 0.26, suggesting Contineum Therapeutics, Inc. is a Buy
-
Contineum Therapeutics, Inc. Relative Strength Index (RSI) is 53.56, which suggest Contineum Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Contineum Therapeutics, Inc. is (10.86 - 12.32), which suggest Contineum Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Contineum Therapeutics, Inc. is (9.44 - 12.4), which suggest Contineum Therapeutics, Inc. is a Buy
* Contineum Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.